The U.S. Supreme Court on Tuesday opted not to hear Johnson & Johnson’s talcum powder case, letting stand a $2.1 billion verdict, but the decision is unlikely to have much impact on thousands of similar lawsuits pending in the courts.

The high court declined to take up the petition, which raised constitutional concerns about both the punitive damages in the jury’s 2018 award, and the judge’s move to consolidate into a single trial the claims of 22 women who blamed their ovarian cancer on Johnson & Johnson’s talc products. Johnson & Johnson’s petition also raised jurisdictional concerns, given that 20 of the women weren’t even from Missouri, where the trial took place in 22nd Judicial Circuit Court in St. Louis.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]